Evidence map›Paper›PMID 38942895›Full record

GuidelineJournal of human hypertension2024

Investigation and management of young-onset hypertension: British and Irish hypertension society position statement.

Spoorthy Kulkarni, Luca Faconti, Sarah Partridge, Christian Delles, Mark Glover, Philip Lewis, Asha Gray, Emma Hodson, Iain Macintyre, Carmen Maniero and 4 more

Abstract readPractice GuidelineReview
In one paragraph

Guideline in Journal of human hypertension, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Spoorthy KulkarniCambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
Luca FacontiKing's College London British Heart Foundation Centre, Department of Clinical Pharmacology, 4th Floor, North Wing, St. Thomas' Hospital, Westminster Bridge, London, SE1 7EH, UK.ORCID 0000-0002-1066-6899
Sarah PartridgeDepartment of Primary Care and Public Health, Brighton and Sussex Medical School, University of Sussex, Brighton, BN1 9PH, UK. s.partridge@bsms.ac.uk.ORCID 0009-0005-8434-2896
Christian DellesSchool of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, G12 8TA, UK.ORCID 0000-0003-2238-2612
Mark GloverDeceased, formerly Division of Therapeutics and Molecular Medicine, School of Medicine, University of Nottingham, Nottingham, NG7 2QL, UK.
Philip LewisStockport NHS Foundation Trust, Stockport, SK2 7JE, UK.ORCID 0000-0002-7903-390X
Asha GrayCambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
Emma HodsonCambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
Iain MacintyreDepartment of Renal Medicine, Royal Infirmary of Edinburgh, National Health Service Lothian, Lothian, EH16 4SA, UK.ORCID 0000-0003-4420-3822
Carmen ManieroWilliam Harvey Research Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Carmel M McEnieryDivision of Experimental Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.ORCID 0000-0003-3636-0705
Manish D SinhaKings College London, Department of Paediatric Nephrology, Evelina London Children's Hospital, Guys & St Thomas NHS Foundation Trust, Westminster Bridge Road, 3rd Floor Beckett House, London, SE1 7EH, UK.ORCID 0000-0001-7593-1203
Stephen B WalshLondon Tubular Centre, Department of Renal Medicine, Royal Free NHS Trust, University College London, London, NW3 2QG, UK.
Ian B WilkinsonDivision of Experimental Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.ORCID 0000-0001-6598-9399

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

National and international hypertension guidelines recommend that adults with young-onset hypertension (aged <40 years at diagnosis) are reviewed by a hypertension specialist to exclude secondary causes of hypertension and optimise therapeutic regimens. A recent survey among UK secondary care hypertension specialist physicians highlighted variations in the investigation of such patients. In this position statement, the British and Irish Hypertension Society seek to provide clinicians with a practical approach to the investigation and management of adults with young-onset hypertension. We aim to ensure that individuals receive consistent and high-quality care across the UK and Ireland, to highlight gaps in the current evidence, and to identify important future research questions.

Indexed as

Age of OnsetHypertensionAdultAntihypertensive AgentsBlood PressureHumansIrelandUnited KingdomAntihypertensive Agents

Identifiers

PMID38942895
PMCPMC11239491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.